IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NQ Hcif GP, Ltd.

Q2 2015 Holdings

Filed 2015-08-03 | 1 holdings | $99.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revance Therapeutics Inc(RVNCEUR)COM761330109$99.0K3,096,650100.0%